Exclusive distribution is evaluated by region, product scope, annual purchase targets, channel coverage, registration investment, and brand-promotion plans. A safer approach is to set a trial period and stage goals first, then sign an exclusive agreement based on actual sales, payments, and market-building results, with clear terms, minimum purchase, pricing, and exit mechanism.

FORNUTRA grounds this in high daily capacity, channel support, and long-term partnership orientation, so capacity, product matrix, and market support underpin exclusivity, but exclusivity must be tied to real investment and results.

For you, this means protecting both parties' market investment and avoiding occupied territory without actual sales. Explore our Turnkey CDMO Solution and Private Label Supplement Manufacturing, or visit About FORNUTRA to apply for a regional program.